Mollayeva, Tatyana

Published purpose

The aim of the call is to establish a number of ambitious, innovative, multi-disciplinary and multi-national expert Working Groups to discuss research strategies that concern the impact of COVID-19 on the development and progression of neurodegenerative disease as well as on the care of patients with neurodegenerative diseases. These strategies can also consider the impact of COVID-19 on neurodegenerative disease research itself, how it is conducted and how it influenced technological innovations for neurodegenerative diseases. Furthermore, they can explore methods and sources of data to enable or improve the surveillance of the impacts of COVID-19 as they relate to the development or progression of neurodegenerative diseases. Working Groups must focus on one or several of the following neurodegenerative diseases: Alzheimer's disease and other dementias Parkinson's disease and PD-related disorders Prion diseases Motor neuron diseases Huntington's disease Spinocerebellar ataxia (SCA) Spinal muscular atrophy (SMA)